- $88.43m
- $91.57m
- BRL807.58m
- 52
- 78
- 52
- 63
Annual income statement for Zenvia, fiscal year end - December 31st, BRL millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 354 | 430 | 612 | 757 | 808 |
Cost of Revenue | |||||
Gross Profit | 93.2 | 104 | 181 | 289 | 331 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 334 | 452 | 659 | 1,046 | 818 |
Operating Profit | 19.8 | -22.1 | -46.5 | -289 | -10.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 17.2 | -29.5 | -65.5 | -333 | -54.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13.8 | -21.4 | -44.6 | -243 | -60.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 13.8 | -21.4 | -44.6 | -243 | -61 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 13.8 | -21.4 | -44.6 | -243 | -61 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.299 | -0.518 | -1.08 | -3.69 | -1.46 |
Dividends per Share |